Intra-venous infusion treatment for diabetic nephropathy

SMUP-IV-01, SMUP allogeneic umbilical cord blood-derived mesenchymal stem cells, is under development for the treatment and prevention of Diabetic Nephropathy. Currently, the non-clinical result of SMUP-IV-01 is undergoing for diabetic nephropathy.